Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 1999

View Archived Issues

Cellular immune responses elicited by HGP-30 AIDS vaccine in mice

AxyS and RPR enter second collaborative agreement

Pharmacopeia enters research collaboration with Pharmacia & Upjohn

Italian research team conducts further studies on resveratrol's mechanism of action

Novartis announces Migranal product introduction in U.K.

Tyrosine kinase and bone resorption inhibitor isolated from fungus by Takeda

FDA committee does not recommend approval of Prograf for GVHD

Nippon Kayaku patents novel squalene synthase inhibitors

Selective D4 antagonists claimed in patent literature by Shionogi

D3-selective chromene derivatives synthesized and evaluated at ADIR

Antimetastatic bis-indoles described in patent literature

NK1 antagonists in early development at Asahi Glass

Comtan progressing toward major market launch

Substance P antagonist prevents emesis in chemotherapy recipients

Wyeth-Ayerst's nonbenzodiazepine hypnotic zaleplon considered approvable by the FDA

Chinese herbal medicines prove effective in some IBS patients

Antex Biologics receives milestone payment from Pasteur Merieux Connaught

IntraBiotics initiates phase I clinical trial of protegrin IB-367 aerosol

Adolor receives patent protection for novel approach to analgesia

Adolor receives additional patent protection for ADL-2-1294

Meta-analysis supports first-line use of inhaled corticosteroids for allergic rhinitis

Dopaminergic compound evaluated in small group of PD patients; no evidence of efficacy

Genome Therapeutics first milestone in alliance with Schering-Plough

JT reports novel antidiabetic agent that has advanced to clinical trials

Thyrogen now on the market in U.S.

Known kappa agonist spiradoline has antiarrhythmic effects in rats

Ferrer selects new compound for clinical development as atypical antipsychotic

DuPont presents potent, orally active antiplatelet agent with good duration of action

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Heartbeam wins appeal, gains FDA clearance
BioWorld MedTech
Management is beaming with delight at Heartbeam Inc. as the company's appeal strategy paid off with U.S. FDA clearance for its synthetic 12-lead electrocardiogram...